Gerhard Jaehne

This inventor holds 59 USPTO granted patents and 6 published patent applications and 17 EPO patents, primarily in Pharmaceutical Chemistry (CPC class A61K). Top assignees: Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh, Sanofi-Aventis. Active years: 1995-2014.

USPTO Granted Patents = 59 (Patent Applications = 6)

% Patents Active = 61.0

EPO Patents = 17 (Patent Applications = 6)

Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 249(Granted Patents)

Forward Citations (Not Self Cited) = 212(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

27 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

patents

25 out of 330

Aventis Pharma Deutschland, Gmbh

Hoechst Aktiengesellschaft

patents

Years Active: 1995-2014

Loading Chart...

Areas of Expertise:

IκB-Kinase Inhibitors

Benzimidazole Derivatives

Diabetes Treatments

Pain Therapy

Medicinal Chemistry

Pharmaceutical Compositions

Obesity Treatment

Dipeptidyl Peptidase Inhibitors

Indole Derivatives

Xanthine Compounds

Aminoalkyl Compounds

Diphenylazetidinones

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8809358 - Use of IκB-kinase inhibitors in pain therapy (2014-08-19),

2. 8778955 - Indole derivatives or benzimidazole derivatives for modulating IkB kinase (2014-07-15),

3. 8236810 - Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV (2012-08-07),

4. 8163774 - Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments (2012-04-24),

5. 8138207 - Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions (2012-03-20),

6. 8003668 - Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders (2011-08-23),

7. 7888343 - Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase (2011-02-15),

8. 7879864 - Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes (2011-02-01),

9. 7838528 - Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their use (2010-11-23),

10. 7795445 - Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use (2010-09-14),

11. 7772429 - Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use (2010-08-10),

12. 7763662 - Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity (2010-07-27),

13. 7759366 - Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use (2010-07-20),

14. 7674773 - Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use (2010-03-09),

15. 7671047 - Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2010-03-02),

Title: The Innovative Journey of Gerhard Jaehne

Introduction: Gerhard Jaehne, a pioneering inventor hailing from Frankfurt, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Gerhard Jaehne holds several patents in various fields, including robotics, artificial intelligence, and renewable energy. His most recent patent focuses on a revolutionary method for optimizing solar panel efficiency, showcasing his commitment to sustainable solutions.

Career Highlights: With a career spanning over three decades, Gerhard Jaehne has established himself as a leading figure in the innovation landscape. His early work in automation systems laid the foundation for his later advancements in the fields of machine learning and data analytics.

Collaborations: Throughout his career, Gerhard Jaehne has collaborated with top research institutions and leading tech companies to bring his inventions to life. His partnerships have led to the development of cutting-edge technologies that have reshaped industries and improved the lives of many.

Conclusion: Gerhard Jaehne's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor. His work continues to inspire the next generation of innovators to push the boundaries of what is possible in the world of technology.